·1 хв читання · 25 слів·👁 6.6K↗ 4
AstraZeneca, Oxford aim to produce Omicron-targeted vaccine
A lab study last week found that AstraZeneca's antibody cocktail Evusheld retained neutralising activity against the Omicron variant.
A lab study last week found that AstraZeneca's antibody cocktail Evusheld retained neutralising activity against the Omicron variant.